93 related articles for article (PubMed ID: 19303540)
1. [Therapeutic targets].
Bueno L
Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S59-67. PubMed ID: 19303540
[TBL] [Abstract][Full Text] [Related]
2. Irritable bowel syndrome: new pharmaceutical approaches to treatment.
Farthing MJ
Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):461-71. PubMed ID: 10580922
[TBL] [Abstract][Full Text] [Related]
3. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
Moskwa A; Boznańska P
Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
[TBL] [Abstract][Full Text] [Related]
4. [Irritable bowel syndrome: pathophysiology and (future) treatment options].
de Schryver AM; Samsom M
Ned Tijdschr Geneeskd; 2002 Jan; 146(1):12-7. PubMed ID: 11802330
[TBL] [Abstract][Full Text] [Related]
5. Protease activated receptor 2: a new target for IBS treatment.
Bueno L
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():95-102. PubMed ID: 18924448
[TBL] [Abstract][Full Text] [Related]
6. The brain-gut axis in irritable bowel syndrome--clinical aspects.
Mach T
Med Sci Monit; 2004 Jun; 10(6):RA125-31. PubMed ID: 15173682
[TBL] [Abstract][Full Text] [Related]
7. Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies.
Johanson JF
Neurogastroenterol Motil; 2004 Dec; 16(6):701-11. PubMed ID: 15601419
[TBL] [Abstract][Full Text] [Related]
8. Design of treatment trials in irritable bowel syndrome: opioid agonists and atypical benzodiazepine antagonists.
Mangel AW; Fehnel SE
Neurogastroenterol Motil; 2008 Oct; 20(10):1086-93. PubMed ID: 18826559
[TBL] [Abstract][Full Text] [Related]
9. Treatment options in irritable bowel syndrome.
Farthing MJ
Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):773-86. PubMed ID: 15324713
[TBL] [Abstract][Full Text] [Related]
10. Mucosal barrier defects in irritable bowel syndrome. Who left the door open?
Barbara G
Am J Gastroenterol; 2006 Jun; 101(6):1295-8. PubMed ID: 16771952
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of current drug therapies in irritable bowel syndrome: what works and does not work.
Schoenfeld P
Gastroenterol Clin North Am; 2005 Jun; 34(2):319-35, viii. PubMed ID: 15862938
[TBL] [Abstract][Full Text] [Related]
12. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.
Kerckhoffs AP; Ter Linde JJ; Akkermans LM; Samsom M
Neurogastroenterol Motil; 2008 Aug; 20(8):900-7. PubMed ID: 18363639
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in the therapy of irritable bowel syndrome.
Saad RJ; Chey WD
Expert Opin Investig Drugs; 2008 Feb; 17(2):117-30. PubMed ID: 18230048
[TBL] [Abstract][Full Text] [Related]
14. Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome.
Barbara G; Stanghellini V; Cremon C; De Giorgio R; Fronzoni L; Serra M; Corinaldesi R
Dig Dis; 2009; 27 Suppl 1():115-21. PubMed ID: 20203507
[TBL] [Abstract][Full Text] [Related]
15. Novel therapeutic targets for enteric nervous system disorders.
De Giorgio R; Barbara G; Furness JB; Tonini M
Trends Pharmacol Sci; 2007 Sep; 28(9):473-81. PubMed ID: 17764756
[TBL] [Abstract][Full Text] [Related]
16. Irritable bowel syndrome: new findings in pathophysiological and therapeutic field.
Catanzaro R; Occhipinti S; Calabrese F; Anzalone MG; Milazzo M; Italia A; Marotta F
Minerva Gastroenterol Dietol; 2014 Jun; 60(2):151-63. PubMed ID: 24780949
[TBL] [Abstract][Full Text] [Related]
17. [Novel therapeutic approaches in the treatment of irritable bowel syndrome].
Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
Orv Hetil; 2007 May; 148(20):923-8. PubMed ID: 17509972
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease.
Spiller R
Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():25-31. PubMed ID: 17620085
[TBL] [Abstract][Full Text] [Related]
19. Postinfectious irritable bowel syndrome.
Barbara G; Cremon C; Pallotti F; De Giorgio R; Stanghellini V; Corinaldesi R
J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S95-7. PubMed ID: 19300138
[TBL] [Abstract][Full Text] [Related]
20. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
